Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors

计划入组 10 人 · 首次发布于 2021 年 7 月 6 日

Trial of CGM Technology in Persons Living With Prediabetes

计划入组 100 人 · 首次发布于 2026 年 6 月 10 日

CGM-097

SA-101

Multiple Myeloma-specific universal CAR T cells(Shenzhen Geno-Immune Medical Institute)

Shenzhen Raysight Intelligent Medical Technology Co., Ltd

China

Shenzhen iShan Technology Co., Ltd

China

Shenzhen Yangan Technology Co., Ltd.

China

ALR Technologies to Acquire CGM Medical in $45 Million Deal, Securing Continuous Glucose Monitor Manufacturing

ALR Technologies Prepares January 2026 Relaunch of GluCurve Pet CGM Following Successful Manufacturing Tests

Medicus Pharma Bolsters Leadership Team, Advances D-MNA for Skin Cancer